Heidelberg Pharma AG Cash Flow Statement

Financials in millions EUR. Fiscal year is December - November.

Millions EUR. Fiscal year is Dec - Nov.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 31, 2025	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020
Net Income	-26.18	-19.38	-20.35	-19.7	-26.14	-18.37
Depreciation & Amortization	0.84	0.84	0.82	0.68	0.75	0.72
Other Amortization	0.04	0.04	0.05	0.08	0.06	0.01
Loss (Gain) From Sale of Assets	0.07	0.06	0.07	-0.01	0.01	0.09
Loss (Gain) From Sale of Investments	-	-	-4.75	-	-	-
Loss (Gain) on Equity Investments	-	-	-	-	0.01	0.07
Stock-Based Compensation	0.5	0.91	0.96	0.55	0.69	0.57
Other Operating Activities	-2.87	-0.06	-0.12	-0.33	0.46	0.01
Change in Accounts Receivable	-0.02	0.69	0.12	-0.08	0.17	0.04
Change in Inventory	-3.91	-1.33	-5.9	-3.84	-0.52	0.01
Change in Accounts Payable	0.43	-2.33	2.12	2.15	-1.91	1.8
Change in Unearned Revenue	-2.37	-4.93	-4.79	10.41	0.26	-1.92
Change in Other Net Operating Assets	1.79	-4.1	-1.91	1.24	-0.45	-0.93
Operating Cash Flow	-31.66	-29.59	-33.67	-8.86	-26.61	-17.89
Capital Expenditures	-0.34	-0.46	-0.94	-0.58	-1.24	-1.37
Sale of Property, Plant & Equipment	-0.01	0.03	0.03	0.02	-	0.2
Sale (Purchase) of Intangibles	-0.02	-0.02	-0.02	-0.03	-0.15	-0.06
Investment in Securities	-	-	6.78	-	-0.01	-0.06
Other Investing Activities	-	-	0	-	-	-0
Investing Cash Flow	-0.36	-0.45	5.85	-0.6	-1.4	-1.29
Short-Term Debt Issued	-	-	-	5	10	-
Total Debt Issued	-	-	-	5	10	-
Short-Term Debt Repaid	-	-5	-10	-	-	-
Long-Term Debt Repaid	-	-0.11	-0.11	-0.09	-0.1	-0.09
Total Debt Repaid	-0.07	-5.11	-10.11	-0.09	-0.1	-0.09
Net Debt Issued (Repaid)	-0.07	-5.11	-10.11	4.91	9.9	-0.09
Issuance of Common Stock	23.15	22.76	0.06	79.91	20.02	14.45
Other Financing Activities	-4.67	-1.58	-0	-0.82	-0.75	-0.06
Financing Cash Flow	18.4	16.08	-10.05	84	29.17	14.29
Foreign Exchange Rate Adjustments	-0.08	-0.06	-0.01	0.65	0	-0.01
Miscellaneous Cash Flow Adjustments	-	0	-	-	-	-
Net Cash Flow	-13.7	-14.02	-37.89	75.19	1.16	-4.9
Free Cash Flow	-32	-30.04	-34.61	-9.45	-27.85	-19.26
Free Cash Flow Margin	-1053.39%	-438.64%	-351.07%	-51.03%	-1369.57%	-222.24%
Free Cash Flow Per Share	-0.68	-0.65	-0.74	-0.25	-0.86	-0.64
Cash Interest Paid	0.01	0.79	0.91	0.53	0.03	0.01
Levered Free Cash Flow	-22.31	-23.51	-21.5	-7.26	-18.84	-12.83
Unlevered Free Cash Flow	-22.3	-23.42	-21.02	-6.74	-18.53	-12.82
Change in Working Capital	-4.09	-11.99	-10.36	9.88	-2.45	-1

Updated Aug 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.